The latest Italy Pharma News, including the government’s decision to make COVID-19 vaccines mandatory for all healthcare workers, the manufacturing of Sputnik V, and recent updates from the country’s top companies, including Chiesi, Angelini Pharma and Menarini.
Doses of Russia’s Sputnik V, made in Italy, to go on sale no sooner than late 2021: TASS
Doses of Russia’s Sputnik V vaccine against COVID-19 produced in Italy by Swiss-based pharmaceutical company Adienne Pharma & Biotech will not be available on the market until at least late 2021, the TASS news agency reported on Friday.
Chiesi and Hephaï join forces to develop AI educational tool to improve inhaler use
Italian pharma company Chiesi and Hephaï, a French start-up developing an AI-based digital education platform, announced their collaboration in developing a digital solution to support improved inhaler use. The platform is designed for patients with asthma and chronic obstructive pulmonary disease (COPD); it aims to help them better control their condition. The app will be available on Apple and Android in 2022.
Menarini and Nippon Shinyaku formalize agreement to commercialize rare disease drug Elzonris in Japan
The Menarini Group announced today that it has entered into an exclusive license agreement for the development and commercialization of ELZONRIS® (tagraxofusp) in the territory of Japan with Nippon Shinyaku. ELZONRIS is approved for the treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) by the U.S. Food and Drug Administration and the European Medicines Agency.
Italy’s lengthy COVID-19 curbs spark small business protests
Dozens of small business owners scuffled with police on Tuesday as they tried to force their way into Rome’s parliament square to protest against Italy’s long-running coronavirus restrictions.
“Freedom, freedom,” protesters shouted as police used batons and shields to push them back into an adjacent street. One policeman was injured after he was hit on the head by an object hurled at him from the crowd, local media reported.
Angelini Pharma Chooses AiDEA’s Artificial Intelligence to Boost Its Digital Transformation and International Growth
Trueblue, a leading provider of AI solutions for the pharma and life sciences markets, has announced that Angelini Pharma, as part of a major global digital transformation process, has selected AiDEA, the first AI-Digital Cloud Pharma CRM solution based on Microsoft technologies.
Italy is making all health workers take the COVID-19 vaccine, and said anyone who refuses will be suspended without pay
Italy made COVID-19 vaccines mandatory for all health workers on Wednesday, with those who refuse facing suspension without pay. The decree, passed by the cabinet of Prime Minister Mario Draghi, is intended to prevent outbreaks in hospitals and protect patients.
“The aim of the measure is to protect as much as possible both medical and paramedical staff and those who are in environments that may be more exposed to the risk of infection,” the government said Wednesday
Add Your Comment
You must be logged in to post a comment.